```html

Killer Cough (Pertussis)

What is Killer cough (pertussis)?

Pertussis, commonly known as “whooping cough” or “killer cough,” is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis. The disease is characterized by severe, protracted coughing fits that often end with a high‑pitched “whoop” as the patient gasps for air. In infants and young children, the cough can lead to vomiting, apnea (temporary cessation of breathing), and even death—hence the historic name “killer cough.” Adults may experience a milder, “cold‑like” illness, but they can still spread the infection to vulnerable infants.

Pertussis is vaccine‑preventable, yet outbreaks still occur worldwide, especially in communities with low immunization rates. The incubation period is typically 7‑10 days (up to 21 days), and the illness progresses through three phases: catarrhal, paroxysmal, and convalescent. Understanding the disease’s natural history helps patients recognize when to seek care and adhere to treatment guidelines.

Common Causes

While Bordetella pertussis is the primary cause of classic pertussis, several other conditions can mimic a “killer cough.” Recognizing these differentials is essential for accurate diagnosis.

• Viral respiratory infections – RSV, influenza, adenovirus, and parainfluenza can produce persistent coughs with wheeze.
• Mycoplasma pneumoniae infection – Often called “atypical pneumonia,” it causes a dry, hacking cough lasting weeks.
• Chlamydia pneumoniae – Another atypical bacterium that presents with prolonged cough.
• Allergic rhinitis & post‑nasal drip – Irritates the throat and leads to chronic cough.
• Asthma – Can manifest as cough‑variant asthma, especially at night.
• Gastro‑esophageal reflux disease (GERD) – Acid reflux irritates the airway and triggers cough.
• Bronchiectasis – Permanent dilation of bronchi resulting in a productive, foul‑smelling cough.
• Foreign body aspiration – Particularly in children, a lodged object can cause sudden, severe coughing.
• Tobacco smoke exposure – Irritates the airway and prolongs recovery from any cough.
• Whooping cough vaccine failure – Immunity wanes over time; adults can develop pertussis despite prior vaccination.

Associated Symptoms

Symptoms vary by disease stage and patient age.

• Catarrhal stage (1‑2 weeks): Low‑grade fever, runny nose, mild sore throat, and a “common cold”‑like cough.
• Paroxysmal stage (2‑6 weeks): Sudden, violent coughing fits lasting 1‑2 minutes, often ending with a high‑pitched “whoop,” vomiting, facial flushing, and exhaustion.
• Convalescent stage (weeks‑months): Cough gradually lessens but may persist for several weeks; coughing can be triggered by laughter, exercise, or cold air.
• Infants (<6 months): May lack the classic whoop; instead they present with apnea, cyanosis, or seizures during coughing episodes.
• Other systemic signs: Low‑grade fever, mild headache, loss of appetite, and weight loss from repeated vomiting.

When to See a Doctor

Because pertussis can progress rapidly, especially in young children, prompt medical evaluation is crucial.

• Any infant (<12 months) with a cough, especially if accompanied by choking, vomiting, or a pause in breathing.
• Cough lasting more than 2 weeks that is worsening or is followed by a high‑pitched gasp.
• Repeated vomiting after coughing fits.
• Fever higher than 38.5 °C (101.3 °F) that does not improve with over‑the‑counter medications.
• Persistent cough that interferes with sleep, eating, or daily activities.
• Exposure to a confirmed case of pertussis, particularly for pregnant women, newborns, or unvaccinated individuals.

In all the situations above, contact a primary‑care provider or urgent‑care clinic promptly. If any red‑flag symptoms (see the next section) appear, call emergency services immediately.

Diagnosis

Diagnosing pertussis involves a combination of clinical assessment and laboratory testing.

Clinical Evaluation

• Detailed history – Onset, duration, exposure to sick contacts, vaccination status.
• Physical exam – Listen for the “whoop,” post‑tussive emesis, and assess for signs of respiratory distress.

Laboratory Tests

• Nasal or nasopharyngeal swab PCR – Most sensitive test; detects bacterial DNA within the first 3 weeks of illness.
• Culture – Gold standard but less commonly used because it requires special media and takes 7‑10 days for results.
• Serology – Measurement of anti‑pertussis toxin IgG antibodies; useful after 2 weeks of symptom onset or when PCR is unavailable.

Additional Tests (if needed)

• Chest X‑ray – To rule out pneumonia, especially in infants or older adults.
• Complete blood count – May show lymphocytosis, a classic finding in pertussis.
• Pulse oximetry – To monitor oxygen saturation during severe coughing fits.

Treatment Options

Treatment aims to eradicate the bacteria, shorten the infectious period, relieve symptoms, and prevent complications.

Antibiotic Therapy

• Macrolides (first‑line):
  • Azithromycin 10 mg/kg on day 1, then 5 mg/kg on days 2‑5 (max 500 mg daily).
  • Erythromycin 40–50 mg/kg/day divided q6h for 7 days (more gastrointestinal side‑effects).
• Alternative agents for macrolide‑resistant strains or intolerance:
  • Trimethoprim‑sulfamethoxazole (TMP‑SMX) 8 mg/kg/day of TMP divided q12h for 5‑7 days.

Antibiotics are most effective when started within the first 3 weeks of cough; they markedly reduce transmission but may have limited impact on cough duration if given later.

Symptomatic & Supportive Care

• Hydration – Encourage frequent small sips of water or oral rehydration solutions.
• Humidified air – Use a cool‑mist humidifier to soothe irritated airways.
• Positioning – Hold infants upright during and after feeds to reduce aspiration risk.
• Medication avoidance – Cough suppressants and antihistamines are generally ineffective and may worsen secretions in pertussis.
• Nutrition – Small, frequent meals; consider high‑calorie formulas for infants who are vomiting.

Hospital Care (when indicated)

• Continuous pulse‑ox monitoring for infants or patients with severe apnea.
• Oxygen therapy or assisted ventilation if oxygen saturation falls below 90 %.
• Intravenous fluids for dehydration or inability to feed.
• Isolation – Airborne precautions (N95 mask for staff, private room) for at least 5 days after antibiotics start.

Prevention Tips

• Vaccination – The DTaP series (5 doses) in childhood and Tdap booster at age 11‑12, then every 10 years for adults.
• Pregnant women should receive Tdap during each pregnancy (ideally 27‑36 weeks) to protect newborns via trans‑placental antibodies.
• Stay up to date on the booster schedule, especially healthcare workers, teachers, and caregivers.
• Practice good respiratory hygiene: cover coughs with a tissue or elbow, dispose of tissues, and wash hands frequently.
• Avoid close contact with individuals who have a persistent cough, especially infants and immunocompromised people.
• Limit exposure to tobacco smoke and indoor pollutants that irritate the airway.
• For households with an infected member, keep infants at least 2 meters (6 feet) away and clean high‑touch surfaces daily with disinfectant.

Emergency Warning Signs

Key Take‑aways

Killer cough (pertussis) remains a serious public‑health concern despite the availability of an effective vaccine. Early recognition, prompt antibiotic treatment, and supportive care can prevent severe outcomes, especially in infants. Vaccination of pregnant women, children, and adults—combined with diligent hygiene—offers the best protection. If you or a loved one experiences a prolonged, severe cough with any of the warning signs listed above, seek medical attention without delay.

Sources: Mayo Clinic, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, The Lancet Respiratory Medicine, JAMA Pediatrics.

```